Leptin Deficiency-Induced Obesity Affects the Density of Mast Cells in Abdominal Fat Depots and Lymph Nodes in Mice

• Obesity causes changes throughout the body, including the immune system. This study found obesity alters immune cells called mast cells in abdominal fat tissue, contributing to chronic inflammation.
• Understanding these biological mechanisms helps explain why bariatric surgery improves conditions beyond just weight loss.
• This is the only basic science publication on Dr. de la Cruz-Muñoz's CV, reflecting translational research bridging lab science and clinical care.
• This reinforces that obesity is a complex biological disease with measurable immune and inflammatory changes that bariatric surgery can address.

Why This Study Was Needed

Obesity is not only extra weight; it is a state of chronic, low-grade inflammation that contributes to insulin resistance, diabetes and heart disease. Mast cells, immune cells best known for their role in allergies, had been linked to obesity and insulin resistance, but little was known about where they accumulate in the body when obesity develops.

How the Study Was Done

This laboratory study, on which Dr. de la Cruz-Muñoz is a co-author, used ob/ob mice, which cannot make the hormone leptin and become severely obese with insulin resistance. Researchers measured mast cell density in abdominal fat depots, skeletal muscle, liver, lymph nodes, spleen and thymus, and identified mast cells carrying TNF-α, an inflammatory signal involved in insulin resistance.

What the Study Found

• In obese mice, mast cells increased about 20-fold in deep (visceral-type) abdominal fat but decreased about 13-fold in fat under the skin.
• A higher share of mast cells in deep abdominal fat carried the inflammatory signal TNF-α.
• Mast cells increased in all abdominal lymph node stations studied.
• There was no significant change in muscle, liver, spleen or thymus.

What This Means for Patients

This work helps explain why deep belly fat is more harmful than fat under the skin, a topic we cover in visceral vs. subcutaneous fat. Obesity reshapes the immune system inside abdominal fat, which supports the view that why obesity is a metabolic disease. It also helps explain why bariatric surgery improves conditions such as diabetes and inflammation beyond what weight loss alone would predict. Hormonal problems such as leptin resistance are part of the same biology.

Strengths and Limitations

Using a well-defined animal model allowed precise tissue measurements that are impossible in people. Results in mice do not always translate to humans, and leptin deficiency is a rare cause of obesity in people.

Expert Commentary

This is the basic science side of what I see in the operating room. The fat deep in the abdomen looks and behaves differently from fat under the skin, and this study shows that it is also biologically different, full of inflammatory immune cells. That is part of why treating obesity improves so many other diseases.

— Dr. Nestor de la Cruz-Muñoz